Prednisone Recruiting Phase 2 Trials for Prostatic Neoplasms Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03007732Pembrolizumab in Combination With Intratumoral SD-101 Therapy
NCT02453009Addition of Enzalutamide to First Line Docetaxel for Castration Resistant Prostate Cancer